MARQUETTA COLBERT: Open Payments
NPI 1891932208 · TROTWOOD, OH. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,681 in 141 payments from 25 companies in 2025. Trend: 2023 $2,400 · 2024 $1,896 · 2025 $2,681
Food & beverage: $2,681
| Company | Payments | Amount |
|---|---|---|
| Gilead Sciences, Inc. | 18 | $330 |
| AstraZeneca Pharmaceuticals LP | 15 | $294 |
| ABBVIE INC. | 22 | $274 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 10 | $239 |
| Novo Nordisk Inc | 13 | $196 |
| Bayer Healthcare Pharmaceuticals Inc. | 14 | $192 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 4 | $168 |
| Astellas Pharma US Inc | 8 | $146 |
| Lundbeck LLC | 4 | $99 |
| Otsuka America Pharmaceutical, Inc. | 4 | $98 |
Products named: CAPLYTA, Kerendia, JARDIANCE, REXULTI, Veozah, AIRSUPRA, BREZTRI, Ozempic.
Industry payments across OH — which companies pay providers there.
